Smart Drugs “As Common As Coffee”: Media Hype about Neuroenhancement - PLoS ONE article

Par Pharmaceutical Begins Shipment of Generic Provigil - MarketWatch

Teva unveils generic Provigil

A small study published in 2009 suggests Provigil may have some addictive potential. This goes against the common wisdom about the drug. More research is needed. A blog entry at ScienceBlogs concluded the addictive potential is not much to worry about.

The Economist: Provigil and Ritalin really do enhance cognition in healthy people. Provigil, for example, adds the ability to remember an extra digit or so to an individual's working memory

Ready for takeoff? A critical review of armodafinil and modafinil for the treatment of sleepiness associated with jet lag

Varsity newspaper: students and academics turn to Provigil and other drugs

One in five people who responded to a survey in Nature magazine, a technical bioscience journal, admitted to using prescription drugs to improve their memory, focus or concentration. Time magazine: Popping Smart Pills: The Case for Cognitive Enhancement

Soldiers Given Drugs to Enhance Performance

Nature survey finds widespread use of performance-enhancing prescription drugs.

FDA monitoring cases of skin reactions associated with Provigil use.

Provigil to address of sleepiness from chronic shift work sleep disorder

Technology Review story on Brain Boosters

Some evidence that modafinil may have addictive potential

Modafinil occupies dopamine and norepinephrine transporters in vivo

Modafinil for atypical depression

UK army tested Provigil - BBC - Oct 2006

A Dose Of Genius - 'Smart Pills' Are on The Rise. But Is Taking Them Wise? - Washington Post

FDA Panel Opposes Use of Provigil to Treat ADHD in Children - March 2006

Modafinil Approved for Shift Work Sleep Disorder in Canada, Feb 2006

UK Defense Ministry to test whether Provigil could be used to reduce the amount of sleep needed by servicemen, Feb 2005

Strange Food for Thought - Christian Science Monitor story on Provigil and similar drugs, June 2004